Orion Biotech Opportunities Corp.

OTCPK:ORIA Stock Report

Market Cap: US$255.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Orion Biotech Opportunities Management

Management criteria checks 0/4

Key information

Ruijin , James Huang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure2yrs

Recent management updates

No updates

Recent updates

CEO

Ruijin , James Huang (56 yo)

no data

Tenure

Mr. Zuie-Chin Huang, M.B.A., also known as Ruijin, James, is Non-Executive Director at Kindstar Global (Beijing) Technology, Inc. since February 8, 2021. He joined the Group as Director in January 30, 2012...

Board Members

NamePositionTenureCompensationOwnership
Zuie-Chin Huang
CEO & Directorno datano datano data
Robert Simonds
General Counselno datano datano data
John Phelan
Strategic Advisorno datano datano data
Samuel Broder
Independent Director2yrsno data0.16%
$ 409.2k
Robert Platek
Strategic Advisorno datano datano data
James Collins
Independent Director2yrsno data0.16%
$ 409.2k
Louisa Rodriguez
Independent Director2yrsno data0.16%
$ 409.2k

2.0yrs

Average Tenure

57yo

Average Age

Experienced Board: ORIA's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/05/18 14:07
End of Day Share Price 2023/05/04 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Orion Biotech Opportunities Corp. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.